Irene Sainz Machín
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Irene Sainz Machín has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Alba Puente-Sanz
Neural Therapies SL. Edif. Institutos de Investigación, Planta baja, Local B43. Campus de Vegazana s/n, 24071 León, Spain
1 shared publication - Amanda Herrero-González
Neural Therapies SL., 24007 León, Spain; Dept. of Cell Biology and Biochemistry, University of León, León, Spain
1 shared publication - Blanca Lorente-Torres
Departamento de Biología Molecular, Área de Microbiología, Universidad de León, 24071 León, Spain
1 shared publication - Eva Martín Gómez
Departamento de Biología Molecular, Área de Microbiología, Universidad de León, 24071 León, Spain
1 shared publication - Farzaneh Javadimarand
Departamento de Biología Molecular, Área de Microbiología, Universidad de León, 24071 León, Spain
1 shared publication - Helena Á. Ferrero
Departamento de Biología Molecular, Área de Microbiología, Universidad de León, 24071 León, Spain
1 shared publication
Latest Publications
- Open Access
- 29 July 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (8) , 765
Streamlining Bacillus Strain Selection Against Listeria monocytogenes Using a Fluorescence-Based Infection Assay Integrated into a Multi-Tiered Validation Pipeline
Background/Objectives: Listeria monocytogenes is a foodborne pathogen of major public health concern due to its ability to invade host cells and cause severe illness. This study aimed to develop and validate a multi-tiered screening pipeline to identify Bacillus strains with probiotic potential against L. monocytogenes. Methods: A total of 26 Bacillus isolates were screened for antimicrobial activity, gastrointestinal resilience, and host cell adhesion. A fluorescence-based infection assay using mCherry-expressing HCT 116 cells was used to assess cytoprotection against L. monocytogenes NCTC 7973. Eight strains significantly improved host cell viability and were validated by quantification of intracellular CFU. Two top candidates were tested in a murine model of listeriosis. The genome of the lead strain was sequenced to evaluate safety and biosynthetic potential. Results: B. subtilis CECT 8266 completely inhibited intracellular replication of L. monocytogenes in HCT 116 cells, reducing bacterial recovery to undetectable levels. In vivo, it decreased splenic bacterial burden by approximately 6-fold. Genomic analysis revealed eight bacteriocin biosynthetic clusters and silent antibiotic resistance genes within predicted genomic islands, as determined by CARD and Alien Hunter analysis. The strain also demonstrated bile and acid tolerance, as well as strong adhesion to epithelial cells. Conclusions: The proposed pipeline enables efficient identification of probiotic Bacillus strains with intracellular protective activity. B. subtilis CECT 8266 is a promising candidate for translational applications in food safety or health due to its efficacy, resilience, and safety profile.
- 29 July 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (8) , 765
Open AccessStreamlining Bacillus Strain Selection Against Listeria monocytogenes Using a Fluorescence-Based Infection Assay Integrated into a Multi-Tiered Validation Pipeline
Background/Objectives: Listeria monocytogenes is a foodborne pathogen of major public health concern due to its ability to invade host cells and cause severe illness. This study aimed to develop and validate a multi-tiered screening pipeline to identify Bacillus strains with probiotic potential against L. monocytogenes. Methods: A total of 26 Bacillus isolates were screened for antimicrobial activity, gastrointestinal resilience, and host cell adhesion. A fluorescence-based infection assay using mCherry-expressing HCT 116 cells was used to assess cytoprotection against L. monocytogenes NCTC 7973. Eight strains significantly improved host cell viability and were validated by quantification of intracellular CFU. Two top candidates were tested in a murine model of listeriosis. The genome of the lead strain was sequenced to evaluate safety and biosynthetic potential. Results: B. subtilis CECT 8266 completely inhibited intracellular replication of L. monocytogenes in HCT 116 cells, reducing bacterial recovery to undetectable levels. In vivo, it decreased splenic bacterial burden by approximately 6-fold. Genomic analysis revealed eight bacteriocin biosynthetic clusters and silent antibiotic resistance genes within predicted genomic islands, as determined by CARD and Alien Hunter analysis. The strain also demonstrated bile and acid tolerance, as well as strong adhesion to epithelial cells. Conclusions: The proposed pipeline enables efficient identification of probiotic Bacillus strains with intracellular protective activity. B. subtilis CECT 8266 is a promising candidate for translational applications in food safety or health due to its efficacy, resilience, and safety profile.